Apolipoprotein C3 deficiency results in diet-induced obesity and aggravated insulin resistance in mice

Diabetes

Volumn 54, Issue 3, 2005, Pages 664-671

  Duivenvoorden, Ilse ^a,b   Teusink, Bas ^a   Rensen, Patrick C ^a,b   Romijn, Johannes A ^b   Havekes, Louis M ^a,b   Voshol, Peter J ^a,b  

^a TNO   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; APOLIPOPROTEIN C3; FATTY ACID; GLUCOSE; INSULIN; LIPOPROTEIN LIPASE; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY FAT; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; DIET; ENZYME ACTIVITY; FATTY ACID TRANSPORT; FEMALE; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN DEFICIENCY; TRIACYLGLYCEROL BLOOD LEVEL; WILD TYPE;

ADIPOSE TISSUE; ANIMALS; APOLIPOPROTEIN C-III; APOLIPOPROTEINS C; BLOOD GLUCOSE; DIETARY FATS; FATTY ACIDS; FEMALE; INSULIN RESISTANCE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OBESITY; TIME FACTORS; TRIGLYCERIDES;

EID: 14644424568     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.54.3.664     Document Type: Article

References (42)

1. Goldberg IJ: Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. J Lipid Res 37:693-707, 1996
2. Zechner R, Strauss J, Frank S, Wagner E, Hofmann W, Kratky D, Hiden M, Levak-Frank S: The role of lipoprotein lipase in adipose tissue development and metabolism. Int J Obes Relat Metab Disord 24 (Suppl. 4):S53-S56, 2000
3. Ferreira LD, Pulawa LK, Jensen DR, Eckel RH: Overexpressing human lipoprotein lipase in mouse skeletal muscle is associated with insulin resistance. Diabetes 50:1064-1068, 2001
4. Kim JK, Fillmore JJ, Chen Y, Yu C, Moore IK, Pypaert M, Lutz EP, Kako Y, Velez-Carrasco W, Goldberg IJ, Breslow JL, Shulman GI: Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance. Proc Natl Acad Sci USA 98:7522-7527, 2001
5. Voshol PJ, Jong MC, Dahlmans VE, Kratky D, Levak-Frank S, Zechner R, Romijn JA, Havekes LM: In muscle-specific lipoprotein lipase-overexpressing mice, muscle triglyceride content is increased without inhibition of insulin-stimulated whole-body and muscle-specific glucose uptake. Diabetes 50:2585-2590, 2001
6. Weinstock PH, Levak-Frank S, Hudgins LC, Radner H, Friedman JM, Zechner R, Breslow JL: Lipoprotein lipase controls fatty acid entry into adipose tissue, but fat mass is preserved by endogenous synthesis in mice deficient in adipose tissue lipoprotein lipase. Proc Natl Acad Sci U S A 94:10261-10266, 1997
7. Goudriaan JR, Tacken PJ, Dahlmans VE, Gijbels MJ, van Dijk KW, Havekes LM, Jong MC: Protection from obesity in mice lacking the VLDL receptor. Arterioscler Thromb Vasc Biol 21:1488-1493, 2001
8. Jong MC, Voshol PJ, Muurling M, Dahlmans VE, Romijn JA, Pijl H, Havekes LM: Protection from obesity and insulin resistance in mice overexpressing human apolipoprotein C1. Diabetes 50:2779-2785, 2001
9. Yagyu H, Lutz EP, Kako Y, Marks S, Hu Y, Choi SY, Bensadoun A, Goldberg IJ: Very low density lipoprotein (VLDL) receptor-deficient mice have reduced lipoprotein lipase activity: possible causes of hypertriglyceridemia and reduced body mass with VLDL receptor deficiency. J Biol Chem 277:10037-10043, 2002
10. Hensley LL, Ranganathan G, Wagner EM, Wells BD, Daniel JC, Vu D, Semenkovich CF, Zechner R, Kern PA: Transgenic mice expressing lipoprotein lipase in adipose tissue: absence of the proximal 3′-untranslated region causes translational upregulation. J Biol Chem 278:32702-32709, 2003
11. Preiss-Landl K, Zimmermann R, Hammerle G, Zechner R: Lipoprotein lipase: the regulation of tissue-specific expression and its role in lipid and energy metabolism. Curr Opin Lipidol 13:471-481, 2002
12. Maeda N, Li H, Lee D, Oliver P, Quarfordt SH, Osada J: Targeted disruption of the apolipoprotein C-III gene in mice results in hypotriglyceridemia and protection from postprandial hypertriglyceridemia. J Biol Chem 269:23610-23616, 1994
13. Shachter NS: Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism. Curr Opin Lipidol 12:297-304, 2001
14. Jong MC, Rensen PC, Dahlmans VE, van der BH, van Berkel TJ, Havekes LM: Apolipoprotein C-III deficiency accelerates triglyceride hydrolysis by lipoprotein lipase in wild-type and apoE knockout mice. J Lipid Res 42: 1578-1585, 2001
15. Zambon A, Hashimoto SI, Brunzell JD: Analysis of techniques to obtain plasma for measurement of levels of free fatty acids. J Lipid Res 34:1021-1028, 1993
16. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275, 1951
17. Rensen PC, Herijgers N, Netscher MH, Meskers SC, van Eck M, van Berkel TJ: Particle size determines the specificity of apolipoprotein E-containing triglyceride-rich emulsions for the LDL receptor versus hepatic remnant receptor in vivo. J Lipid Res 38:1070-1084, 1997
18. Teusink B, Voshol PJ, Dahlmans VE, Rensen PC, Pijl H, Romijn JA, Havekes LM: Contribution of fatty acids released from lipolysis of plasma triglycerides to total plasma fatty acid flux and tissue-specific fatty acid uptake. Diabetes 52:614-620, 2003
19. Zechner R: Rapid and simple isolation procedure for lipoprotein lipase from human milk. Biochim Biophys Acta 1044:20-25, 1990
20. Rensen PC, van Berkel TJ: Apolipoprotein E effectively inhibits lipoprotein lipase-mediated lipolysis of chylomicron-like triglyceride-rich lipid emulsions in vitro and in vivo. J Biol Chem 271:14791-14799, 1996
21. Koopmans SJ, Jong MC, Que I, Dahlmans VE, Pijl H, Radder JK, Frolich M, Havekes LM: Hyperlipidaemia is associated with increased insulin-mediated glucose metabolism, reduced fatty acid metabolism and normal blood pressure in transgenic mice overexpressing human apolipoprotein C1. Diabetologia 44:437-443, 2001
22. Bligh EG, Dyer WJ: A rapid method of total lipid extraction and purification. Can J Med Sci 37:911-917, 1959
23. Havekes LM, de Wit EC, Princen HM: Cellular free cholesterol in Hep G2 cells is only partially available for down-regulation of low-density-lipoprotein receptor activity. Biochem J 247:739-746, 1987
24. Post SM, de Wit EC, Princen HM: Cafestol, the cholesterol-raising factor in boiled coffee, suppresses bile acid synthesis by downregulation of cholesterol 7 alpha-hydroxylase and sterol 27-hydroxylase in rat hepatocytes. Arterioscler Thromb Vasc Biol 17:3064-3070, 1997
25. Kahn BB, Flier JS: Obesity and insulin resistance. J Clin Invest 106:473-481, 2000
26. Laplante M, Sell H, MacNaul KL, Richard D, Berger JP, Deshaies Y: PPAR-γ activation mediates adipose depot-specific effects on gene expression and lipoprotein lipase activity: mechanisms for modulation of postprandial lipemia and differential adipose accretion. Diabetes 52:291-299, 2003
27. Berger J, Moller DE: The mechanisms of action of PPARs. Annu Rev Med 53:409-435, 2002
28. Goldberg IJ, Merkel M: Lipoprotein lipase: physiology, biochemistry, and molecular biology. Front Biosci 6:D388-D405, 2001
29. Jensen DR, Schlaepfer IR, Morin CL, Pennington DS, Marcell T, Ammon SM, Gutierrez-Hartmann A, Eckel RH: Prevention of diet-induced obesity in transgenic mice overexpressing skeletal muscle lipoprotein lipase. Am J Physiol 273:R683-R689, 1997
30. Olivecrona G, Olivecrona T: Triglyceride lipases and atherosclerosis. Curr Opin Lipidol 6:291-305, 1995
31. Zechner R: The tissue-specific expression of lipoprotein lipase: implications for energy and lipoprotein metabolism. Curr Opin Lipidol 8:77-88, 1997
32. Goudriaan JR, Espirito Santo SM, Voshol PJ, Teusink B, van Dijk KW, van Vlijmen BJ, Romijn JA, Havekes LM, Rensen PC: The VLDL receptor plays a major role in chylomicron metabolism by enhancing LPL-mediated triglyceride hydrolysis. J Lipid Res 45:1475-1481, 2004
33. Schaap FG, Rensen PC, Voshol PJ, Vrins C, van der Vliet HN, Chamuleau RA, Havekes LM, Groen AK, van Dijk KW: ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis. J Biol Chem 279:27941-27947, 2004
34. Haemmerle G, Zimmermann R, Strauss JG, Kratky D, Riederer M, Knipping G, Zechner R: Hormone-sensitive lipase deficiency in mice changes the plasma lipid profile by affecting the tissue-specific expression pattern of lipoprotein lipase in adipose tissue and muscle. J Biol Chem 277:12946-12952, 2002
35. Ceddia RB, Koistinen HA, Zierath JR, Sweeney G: Analysis of paradoxical observations on the association between leptin and insulin resistance. FASEB J 16:1163-1176, 2002
36. Silha JV, Krsek M, Skrha JV, Sucharda P, Nyomba BL, Murphy LJ: Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur J Endocrinol 149:331-335, 2003
37. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA: The hormone resistin links obesity to diabetes. Nature 409:307-312, 2001
38. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T: The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7:941-946, 2001
39. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL: Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334:292-295, 1996
40. Hintz KK, Aberle NS, Ren J: Insulin resistance induces hyperleptinemia, cardiac contractile dysfunction but not cardiac leptin resistance in ventricular myocytes. Int J Obes Relat Metab Disord 27:1196-1203, 2003
41. Piatti P, Di Mario C, Monti LD, Fragasso G, Sgura F, Caumo A, Setola E, Lucotti P, Galluccio E, Ronchi C, Origgi A, Zavaroni I, Margonato A, Colombo A: Association of insulin resistance, hyperleptinemia, and impaired nitric oxide release with in-stent restenosis in patients undergoing coronary stenting. Circulation 108:2074-2081, 2003
42. Steinberger J, Steffen L, Jacobs DR Jr, Moran A, Hong CP, Sinaiko AR: Relation of leptin to insulin resistance syndrome in children. Obes Res 11:1124-1130, 2003